Pfizer

Burrill Merchant Banking Advises Pfizer Inc. on Dermatology Portfolio Divestment

SAN FRANCISCO, July 14 /PRNewswire/ -- Burrill Merchant Banking acted as exclusive financial advisor to Pfizer Inc. on its recently-completed divestment of three investigational compounds for dermatological conditions to Graceway Pharmaceuticals, LLC. Financial terms of the agreement we...

U-M Purchase of Former Pfizer Facility Nears Completion, Paving the Way For Research Expansion and Job Creation

ANN ARBOR, Mich., May 15 /PRNewswire-USNewswire/ -- Within weeks, the University of Michigan will take ownership of a 174-acre research campus that will provide a springboard for new discoveries, job creation and educational opportunity -- and offer a wise investment for U-M's future. U-M's...

GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company

- Creates a new focused HIV business with the independence and sustainability to deliver significant improvements in treatment, access and shareholder value - Renews focus on HIV with industry-leading pipeline to deliver more new HIV treatments - Equity split of 85% GSK and 15% Pfizer ...

As the Number of Unemployed Grows, Pfizer Helpful Answers and SABEResPODER Join Forces to Educate Hispanics Who Lack Health Insurance About How to Access Prescription Medicines

NEW YORK, March 26 /PRNewswire/ -- California has one of the top five highest rates of uninsured Hispanic residents. As more people become uninsured due to the rapidly increasing unemployment rate, Pfizer Helpful Answers, a family of programs that helps people without prescription coverage sa...

VIDEO from Medialink and Pfizer Ophthalmics: On World Glaucoma Day, Keep an Eye on the Future

NEW YORK, March 12 /PRNewswire/ -- On the second annual World Glaucoma Day (March 12), leading global glaucoma experts are working together to help educate patients diagnosed with glaucoma and those who may be at risk for the condition. Glaucoma is a worldwide epidemiological challenge affecting a...

AUDIO from Medialink and Pfizer Ophthalmics: Glaucoma - The Sneak Thief of Sight

NEW YORK, Jan. 13 /PRNewswire/ -- January is Glaucoma Awareness Month. Here are some eye-opening facts to share about the world's second-leading cause of preventable blindness. Listen to this report from Pfizer Ophthalmics at: http://media.medialink.com/WebNR.aspx?story=36168 Registere...

Senator Gordon Smith Joins Virginia Garcia Memorial Health Center and Pfizer to Honor a Community Caregiver

National Health Center Week 2008 Dedicated to Good Health through Health Care Heroes Pfizer Patient Assistance Program Distributed More than $1.5 Million Worth of Free Medicines to Nearly 5,600 Patients of Oregon's Community Health Centers Last Year HILLSBORO, Ore., Aug. 14 /PRNewswire-USN...

CHASS Center, Inc. and Pfizer Honor Health Care Heroes

Special Invited Guest Congresswoman Carolyn Cheeks Kilpatrick to Help Celebrate Community Caregivers during National Health Center Week 2008 Pfizer Patient Assistance Program Distributed More than $1.4 Million Worth of Free Medicines to Nearly 4,000 Patients of Michigan's Community Health Ce...

New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs

Leading personal injury law firm representing families of individuals who suffered from suicidal thoughts and erratic behavior while taking popular smoking cessation drug Mineola, N.Y. (Lexis Nexis) August 5, 2008 - http://thesandersfirm.com/attorney.asp?attorneyid=14 ...

Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris

BIRMINGHAM, Ala., July 9 /PRNewswire/ -- A lawsuit charges pharmaceutical giant Pfizer was motivated by greed when it failed to warn the public of potentially deadly side-effects associated with its popular smoking cessation drug varenicline which is marketed under the trade name Chantix. The ...

More>>

Pfizer in Medical Technology

Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing

PRINCETON, N.J., Sept. 8 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) today announced that it received a milestone payment for an undisclosed amount from its licensing partner, Pfizer Inc. (NYSE: PFE ). This payment is a result of the submission of an Investigational New Drug (IND...

Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial

LONDON, July 30 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN), a leading European RNAi focused biotechnology company, today announces that its partner, Quark Pharmaceuticals Inc. ("Quark") together with Pfizer, has commenced a Phase II clinical trial with RTP-801i-14 (PF-4523655), a smal...

Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema

Clinical Program Leverages Quark's RNAi Technology FREMONT, Calif., July 30 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that its partner, Pfizer Inc, initi...

Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug

SAN JOSE, Calif., Jan. 7 /PRNewswire/ -- Tacere Therapeutics, Inc., an RNA interference (RNAi)-based therapeutics developer, announced today that it has entered into a collaboration and license agreement with Pfizer Inc. to develop and commercialize its Hepatitis C virus (HCV) compound, TT-033...

NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan

SOPHIA ANTIPOLIS, France, Jan. 3 /PRNewswire/ -- NicOx S.A. (Euronext Paris: COX) today announced that Pfizer Inc (NYSE: PFE ) has initiated a dose-ranging phase 2 clinical study for PF-03187207 in Japan. PF-03187207 is a new experimental medicine for the treatment of glaucoma, which is curre...

Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development

- Pfizer-funded Screening Agreement Fuels Discovery of Novel Compounds, Complements Clinical Development Initiatives with PF-3512676 - WELLESLEY, Mass., Oct. 30 /PRNewswire-FirstCall/ -- Coley Pharmaceutical Group, Inc. (Nasdaq: COLY ), a biopharmaceutical company discovering and developi...

Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer

SOUTH SAN FRANCISCO, Calif., Dec. 6 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that its corporate partner, Pfizer (NYSE: PFE ), has begun a Phase 1 clinical trial of an inhaled formulation of Rigel's small molecule syk kinase inhibitor, R343, for th...

New Pfizer Oncology Data Across Numerous Cancer Types to be Presented at ASCO

NEW YORK--(BUSINESS WIRE)--May 29, 2007 - Pfizer said today that results showing potential across numerous types of cancer, such as melanoma, thyroid, liver, non-small cell lung (NSCLC), colorectal (CRC) and renal cell carcinoma (RCC) - a type of advanced kidney cancer - will be presented next week...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

... by unrestricted grants of equal share from Astra Zeneca, Berlin Chemie, Boots Healthcare, Glaxo-Smith-Kline, McNeil Pharma, MSD Sharp & Dohme and pfizer to the University of Muenster. About deCODE deCODE is a bio-pharmaceutical company developing DNA-based tests and drugs to improve the t...

Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value

...ng AD, about Aricept, and for full prescribing information, call 1-888-274-2378 or visit www.aricept.com . Aricept is co-promoted by Eisai Inc. and pfizer Inc. About Eisai Co., Ltd. Eisai Co., Ltd. is a research-based human health care ( hhc ) company that discovers, develops and markets p...

Pfizer in Medical Products

TECNIS Foldable IOL

Description:... Engineers at pfizer used wavefront sensing to invent the TECNIS lens, with Z-SHARP Optic Technology. Innovative TECNIS features a patented modified prolate anterior surfa...
Company:Advanced Medical Optics, Inc.

Pfizer in Medical Dictionary

Trachoma

...people are visually impaired as a result of this... Includes information on trachoma , prevention, treatment, initiative and programs. Founded by pfizer Inc and The Edna McConnell Clark Foundation. Trachoma is the world's leading cause of preventable blindness. 41 million people suffer from ... T...

Titer

...atment. ... ... titer from Webster's New World College Dictionary. Meaning of titer . ... test: The titer tests were conducted by Rod Little, pfizer Global ... titer usage ... ...

Pfizer in Biological News

WARF signs license agreement with Pfizer for human embryonic stem cells

MADISON Pfizer Inc., a major biopharmaceutical company, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin-Madison, announced May 5 that they have signed a license for human embryonic stem (hES) cell pat...

Pfizer shows support for open access

... pfizer today announced details of a membership agreement ...s BioMed Central membership arrangement means that pfizer will centrally cover the publication fees for any researcher employed or funded by pfizer when they submit a research article to one of BioM...

Pfizer supports open access publishing for researchers in low-income countries

... Today, pfizer announced an agreement with BioMed Central to launch an open access waiver ...lication fee. Speaking of the agreement Dr Jack Watters, Vice President, pfizer External Medical Affairs said "Pfizer's support for open access publishing...

Open access research celebrated

...sible." Guests at the event were treated to a lively routine from Brian Malow, 'the science comedian'. As part of their commitment to open access, pfizer were proud to be the sponsor the Research Awards Dinner. Photos and full details of the awards can be found at the BioMed Central Annual Research A...

CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda

...nces, Genentech, Inc.     Mark Fidock, Ph.D., Head, Biochemical and Molecular BioMarkers, Experimental Biological Sciences, pfizer Limited Dorothee Foernzler, Ph.D., Biomarker-Experimental Medicine Leader, F. Hoffmann-La Roche AG Alberto Gutierrez, Ph.D., Deputy Dire...

Developer of advanced computing memory, father of biochemical engineering, and innovative engineering educators win highest engineering honors of 2009

...nized as the primary medium through which worldwide bioprocess engineering research is shared in the profession. After a brief time in industry at pfizer Inc., Gaden spent the remainder of his career in academia, first teaching chemical engineering at his alma mater, Columbia University, followed with t...

Alzheimer's disease research attracts first partner

...agreement with a major strategic alliance partner, pfizer Australia. AIBL is the world's largest study of i...University of Melbourne, says the partnership with pfizer Australia will see a panel of biomarkers tested ag...sease in susceptible individuals." According to pfizer Australia's Head of Strategic Alliances, Dr Daniel...

TheVisualMD.com launches new animated 3-D views of human body in action

...n programming; Nike hired Anatomical Travelogue to produce animated spots revealing the anatomy of a golfer's swing, and drug companies like Amgen and pfizer are using the company's simulations to show how new drugs work at the molecular level. "Along the way, we became great storytellers in categories that...

American Chemical Society's Weekly PressPac -- Aug. 13, 2008

...y in Brooklyn, N.Y., on June 12. The process ushered in the era of antibiotics and represented a turning point in modern medicine. After World War II, pfizer applied its deep-tank fermentation to manufacture the antibiotics streptomycin and Terramycin, which proved effective against a wide range of deadly b...

American Chemical Society's Weekly PressPac -- July 23, 2008

...y in Brooklyn, N.Y., on June 12. The process ushered in the era of antibiotics and represented a turning point in modern medicine. After World War II, pfizer applied its deep-tank fermentation to manufacture the antibiotics streptomycin and Terramycin, which proved effective against a wide range of deadly b...

Pfizer in Biological Technology

Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting

MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) today announced that its stockholders overwhelmingly approved the adoption of its merger agreement with Pfizer (NYSE: PFE ) at Wyeth's Annual Meeting of Stockholders. Based on a preliminary vote count by Wyeth's tra...

GSK and Pfizer Innovative Agreement Creates Specialist HIV Company

LONDON, April 16 /PRNewswire-FirstCall/ -- Pharmaceutical companies GlaxoSmithKline and Pfizer today announced an "innovative agreement" to pool their HIV assets creating a new world-leading, specialist HIV company. The deal will see the drug giants combine their existing HIV product an...

MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant

VALENCIA, Calif., March 9 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD ) today announced that it has entered into agreements with Pfizer Inc. (NYSE: PFE ) to purchase Pfizer's insulin facility at Industriepark Hoechst, Frankfurt am Main, Germany and assets related to the produc...

JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market

JMAR Technologies, Inc. (OTCBB: JMAR), a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced that JMAR's microbial contamination detection expert John A. Ada...

Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods

CAMBRIDGE, England, November 20 /PRNewswire-FirstCall/ -- Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, has signed a Master Service Agreement of up to five years with Pfizer Limited, the UK operating unit of the glo...

Odyssey Thera Announces Milestone Achievement in Pfizer Alliance

SAN RAMON, Calif., Aug. 7 /PRNewswire/ -- Odyssey Thera, Inc. announced that it has received a milestone payment from Pfizer Inc, following Pfizer's decision to progress a discovery stage drug candidate into pre-clinical development. The drug candidate was extensively studied by Odyssey Thera ...

QSV Biologics awarded cGMP manufacturing contract by Pfizer Inc.

EDMONTON, May 1 /PRNewswire/ - QSV Biologics, Ltd (QSV), a North American based biologics CMO located in Edmonton, Canada, has been awarded a cGMP manufacturing contract for a recombinant protein under development by Pfizer, Inc. The protein will be manufactured at QSV's Edmonton facility and ...

Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis

Ingenuity Pathways Analysis to be deployed broadly to researchers at Pfizer, integrated with internal solutions REDWOOD CITY, Calif., April 15 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, and Pfizer Pharmaceutica...

Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives

ANN ARBOR, Mich., Oct. 4 /PRNewswire/ -- Richard D. Dyer, PhD, has been appointed Executive Vice President of Product Development for Velcura Therapeutics, Inc., an early stage biotechnology company developing potentially breakthrough therapies to treat bone diseases. "We are pleased to add a...

WuXi PharmaTech Signs New Collaboration Agreement With Pfizer

SHANGHAI, China, Nov. 7 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that it has signed a new three-year, in vitro ADME ...